| Year |
Citation |
Score |
| 2023 |
Giombi K, Thompson J, Wines C, Haughney R, Sullivan HW, Betts KR. A scoping review of empirical research on prescription drug promotion. Research in Social & Administrative Pharmacy : Rsap. PMID 36931982 DOI: 10.1016/j.sapharm.2023.02.012 |
0.315 |
|
| 2022 |
Aikin KJ, O'Donoghue AC, Squire C, Sullivan HW, Betts KR. An Empirical Examination of the FDAAA-Mandated "Toll-Free Statement" for Consumer Reporting of Side Effects in Direct-to-Consumer Television Advertisements. Journal of Public Policy & Marketing : Jpp&M : An Annual Publication of the Division of Research, Graduate School of Business Administration, the University of Michigan. 35: 108-123. PMID 36035636 DOI: 10.1509/jppm.14.077 |
0.308 |
|
| 2021 |
Sullivan HW, Squire C, Aikin KJ, Tzeng J, Ferriola-Bruckenstein K, Brodsky E, Trentacosti AM, Johnson M. Physicians' use of and preferences for FDA-approved prescribing information. Research in Social & Administrative Pharmacy : Rsap. PMID 34364803 DOI: 10.1016/j.sapharm.2021.07.028 |
0.302 |
|
| 2021 |
Aikin KJ, Sullivan HW, Berktold J, Stein KL, Hoverman VJ. Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey. Health Marketing Quarterly. 1-11. PMID 34238134 DOI: 10.1080/07359683.2021.1947067 |
0.335 |
|
| 2020 |
Kelly BJ, Rupert DJ, Aikin KJ, Sullivan HW, Johnson M, Bann CM, Mack N, Southwell BG, West S, Parvanta S, Rabre A, Peinado S. Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising. Research in Social & Administrative Pharmacy : Rsap. PMID 32883618 DOI: 10.1016/J.Sapharm.2020.07.028 |
0.422 |
|
| 2020 |
Sullivan HW, Aikin KJ, Berktold J, Stein KL, Hoverman VJ. Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions. Journal of the American Board of Family Medicine : Jabfm. 33: 279-283. PMID 32179611 DOI: 10.3122/Jabfm.2020.02.190278 |
0.377 |
|
| 2019 |
Sullivan HW, Aikin KJ, David KT, Berktold J, Stein KL, Hoverman VJ. Consumer understanding of the scope of FDA's prescription drug regulatory oversight: A nationally representative survey. Pharmacoepidemiology and Drug Safety. PMID 31833141 DOI: 10.1002/Pds.4914 |
0.389 |
|
| 2019 |
Sullivan HW, O'Donoghue AC, Lynch M, Johnson M, Davis C, Rupert DJ. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X19875946. PMID 31583947 DOI: 10.1177/0272989X19875946 |
0.426 |
|
| 2019 |
O'Donoghue AC, Johnson M, Sullivan HW, Parvanta S, Ray S, Southwell BG. Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation. Journal of Health Communication. 1-9. PMID 31012394 DOI: 10.1080/10810730.2019.1606364 |
0.358 |
|
| 2019 |
DeFrank JT, Berkman ND, Kahwati L, Cullen K, Aikin KJ, Sullivan HW. Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review. Health Communication. 1-8. PMID 30973021 DOI: 10.1080/10410236.2019.1584781 |
0.341 |
|
| 2019 |
O'Donoghue AC, Sullivan HW, Rupert DJ, Fitts Willoughby J, Aikin KJ. Actors in whitespace: Communicating risk information on pharmaceutical websites. Health Marketing Quarterly. 1-16. PMID 30907290 DOI: 10.1080/07359683.2019.1575063 |
0.424 |
|
| 2018 |
Sullivan HW, O'Donoghue AC, David KT, Patel NJ. Disclosing accelerated approval on direct-to-consumer prescription drug websites. Pharmacoepidemiology and Drug Safety. PMID 30264874 DOI: 10.1002/Pds.4664 |
0.398 |
|
| 2018 |
Southwell BG, Parvanta SA, Johnson MM, O'Donoghue AC, Sullivan HW, Ray SE, Soloe CS, Davis CN, McKenna N. Assessing hearing and cognition challenges in consumer processing of televised risk information: Validation of self-reported measures using performance indicators. Preventive Medicine Reports. 11: 145-147. PMID 30003013 DOI: 10.1016/J.Pmedr.2018.06.008 |
0.317 |
|
| 2018 |
Moynihan CK, Burke PA, Evans SA, O'Donoghue AC, Sullivan HW. Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug Promotion. Journal of the American Board of Family Medicine : Jabfm. 31: 645-649. PMID 29986991 DOI: 10.3122/Jabfm.2018.04.170242 |
0.334 |
|
| 2018 |
Sullivan HW, O'Donoghue AC, Gard Read J, Amoozegar JB, Aikin KJ, Rupert DJ. Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions. Journal of Medical Internet Research. 20: e13. PMID 29362205 DOI: 10.2196/Jmir.7959 |
0.428 |
|
| 2017 |
Sullivan H, Boudewyns V, O'Donoghue A, Marshall S, Williams PA. Attention to and Distraction from Risk Information in Prescription Drug Advertising: An Eye Tracking Study. Journal of Public Policy & Marketing : Jpp&M : An Annual Publication of the Division of Research, Graduate School of Business Administration, the University of Michigan. 36: 236-245. PMID 33505105 DOI: 10.1509/Jppm.16.013 |
0.386 |
|
| 2017 |
Sullivan HW, Aikin KJ, Poehlman J. Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis. Health Communication. 1-8. PMID 29125325 DOI: 10.1080/10410236.2017.1399509 |
0.419 |
|
| 2017 |
Aikin KJ, Sullivan HW, Dolina S, Lynch M, Squiers LB. Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis. Journal of Medical Internet Research. 19: e225. PMID 28676469 DOI: 10.2196/Jmir.7306 |
0.4 |
|
| 2017 |
Sullivan HW, O'Donoghue AC, Rupert DJ, Willoughby JF, Aikin KJ. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites. Journal of Health Communication. 1-11. PMID 28129069 DOI: 10.1080/10810730.2016.1258745 |
0.435 |
|
| 2016 |
Aikin KJ, O'Donoghue AC, Sullivan HW, Betts KR, Squire C. Who Said It Better? A Test of Wording Differences in the MedWatch "Toll-Free Statement" for Consumer Reporting of Side Effects in Direct-to-Consumer Television Advertisements. Therapeutic Innovation & Regulatory Science. 50: 169-173. PMID 30227007 DOI: 10.1177/2168479015596023 |
0.39 |
|
| 2016 |
Amoozegar JB, Rupert DJ, Sullivan HW, O'Donoghue AC. Consumer confusion between prescription drug precautions and side effects. Patient Education and Counseling. PMID 28069321 DOI: 10.1016/J.Pec.2016.12.032 |
0.435 |
|
| 2016 |
Aikin KJ, Sullivan HW, O'Donoghue AC, Betts KR. Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers. Health Marketing Quarterly. 33: 291-306. PMID 27841741 DOI: 10.1080/07359683.2016.1238262 |
0.416 |
|
| 2016 |
Rupert DJ, Gard Read J, Amoozegar JB, Moultrie RR, Taylor OM, O'Donoghue AC, Sullivan HW. Peer-Generated Health Information: The Role of Online Communities in Patient and Caregiver Health Decisions. Journal of Health Communication. 1-11. PMID 27805496 DOI: 10.1080/10810730.2016.1237592 |
0.327 |
|
| 2016 |
Sullivan HW, O'Donoghue AC, Rupert DJ, Willoughby JF, Amoozegar JB, Aikin KJ. Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study. Journal of Health Communication. 1-10. PMID 27805473 DOI: 10.1080/10810730.2016.1237594 |
0.424 |
|
| 2016 |
Sullivan HW, Aikin KJ, Squiers LB. Quantitative Information on Oncology Prescription Drug Websites. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. PMID 27589969 DOI: 10.1007/S13187-016-1107-1 |
0.459 |
|
| 2016 |
O'Donoghue AC, Sullivan HW, Williams PA, Squire C, Betts KR, Willoughby JF, Parvanta S. Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads. Journal of Health Communication. 1-8. PMID 27414000 DOI: 10.1080/10810730.2016.1179367 |
0.382 |
|
| 2016 |
Sullivan HW, Aikin KJ, Chung-Davies E, Wade M. Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration. Plos One. 11: e0155035. PMID 27149513 DOI: 10.1371/Journal.Pone.0155035 |
0.397 |
|
| 2016 |
Aikin KJ, O'Donoghue AC, Squire CM, Sullivan HW, Betts KR. An Empirical Examination of the FDAAA-Mandated Toll-Free Statement for Consumer Reporting of Side Effects in Direct-to-Consumer Television Advertisements Journal of Public Policy & Marketing. 35: 108-123. DOI: 10.1509/Jppm.14.077 |
0.433 |
|
| 2015 |
Sullivan HW, O'Donoghue AC, Aikin KJ. Communicating Benefit and Risk Information in Direct-to-Consumer Print Advertisements: A Randomized Study. Therapeutic Innovation & Regulatory Science. 49: 493-502. PMID 30222437 DOI: 10.1177/2168479015572370 |
0.429 |
|
| 2015 |
Sullivan HW, O'Donoghue AC, Aikin KJ, Chowdhury D, Moultrie RR, Rupert DJ. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study. Patient Education and Counseling. PMID 26749356 DOI: 10.1016/J.Pec.2015.12.015 |
0.357 |
|
| 2015 |
Aikin KJ, Sullivan HW, Betts KR. Disease Information in Direct-to-Consumer Prescription Drug Print Ads. Journal of Health Communication. 1-12. PMID 26717304 DOI: 10.1080/10810730.2015.1058440 |
0.422 |
|
| 2015 |
Williams PA, O'Donoghue AC, Sullivan HW, Willoughby JF, Squire C, Parvanta S, Betts KR. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising. Patient Education and Counseling. PMID 26589655 DOI: 10.1016/J.Pec.2015.10.019 |
0.379 |
|
| 2015 |
Sullivan HW, Campbell M. Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration. Journal of Health Communication. 1-6. PMID 26120940 DOI: 10.1080/10810730.2015.1018635 |
0.46 |
|
| 2014 |
O'Donoghue AC, Sullivan HW, Aikin KJ, Betts KR. Important Safety Information or Important Risk Information? A Question of Framing in Prescription Drug Advertisements. Therapeutic Innovation & Regulatory Science. 48: 305-307. PMID 30235532 DOI: 10.1177/2168479013510306 |
0.431 |
|
| 2014 |
Sullivan HW, O'Donoghue AC, Aikin KJ. Primary care physicians' use of FDA-approved prescription drug labels. Journal of the American Board of Family Medicine : Jabfm. 27: 694-8. PMID 25201939 DOI: 10.3122/Jabfm.2014.05.140039 |
0.381 |
|
| 2014 |
O'Donoghue AC, Williams PA, Sullivan HW, Boudewyns V, Squire C, Willoughby JF. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall. Social Science & Medicine (1982). 120: 1-11. PMID 25194471 DOI: 10.1016/J.Socscimed.2014.08.039 |
0.381 |
|
| 2014 |
Rupert DJ, Moultrie RR, Read JG, Amoozegar JB, Bornkessel AS, O'Donoghue AC, Sullivan HW. Perceived healthcare provider reactions to patient and caregiver use of online health communities. Patient Education and Counseling. 96: 320-6. PMID 24923652 DOI: 10.1016/J.Pec.2014.05.015 |
0.313 |
|
| 2014 |
O'Donoghue AC, Sullivan HW, Aikin KJ. Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 48: 311-22. PMID 24682975 DOI: 10.1007/S12160-014-9603-1 |
0.44 |
|
| 2014 |
O'Donoghue AC, Sullivan HW, Aikin KJ, Chowdhury D, Moultrie RR, Rupert DJ. Presenting efficacy information in direct-to-consumer prescription drug advertisements. Patient Education and Counseling. 95: 271-80. PMID 24581929 DOI: 10.1016/J.Pec.2013.12.010 |
0.435 |
|
| 2014 |
O'Donoghue AC, Sullivan HW, Aikin KJ, Betts KR. Important safety information or important risk information? A question of framing in prescription drug advertisements Therapeutic Innovation and Regulatory Science. 48: 305-307. DOI: 10.1177/2168479013510306 |
0.314 |
|
| 2013 |
West SL, Squiers LB, McCormack L, Southwell BG, Brouwer ES, Ashok M, Lux L, Boudewyns V, O'Donoghue A, Sullivan HW. Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising. Pharmacoepidemiology and Drug Safety. 22: 447-58. PMID 23440924 DOI: 10.1002/Pds.3416 |
0.449 |
|
| 2011 |
Aikin KJ, O'Donoghue AC, Swasy JL, Sullivan HW. Randomized trial of risk information formats in direct-to-consumer prescription drug advertisements. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 31: E23-33. PMID 21690303 DOI: 10.1177/0272989X11413289 |
0.446 |
|
| 2010 |
Sullivan HW, Finney Rutten LJ, Waters EA. Requests for cancer prevention information: the cancer information service (2002-2006). Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 25: 16-22. PMID 20082170 DOI: 10.1007/S13187-009-0003-3 |
0.301 |
|
| 2009 |
Sullivan HW, Finney Rutten LJ. Cancer prevention information seeking: a signal detection analysis of data from the cancer information service. Journal of Health Communication. 14: 785-96. PMID 20029711 DOI: 10.1080/10810730903295534 |
0.322 |
|
| 2009 |
Waters EA, Sullivan HW, Nelson W, Hesse BW. What is my cancer risk? How internet-based cancer risk assessment tools communicate individualized risk estimates to the public: content analysis. Journal of Medical Internet Research. 11: e33. PMID 19674958 DOI: 10.2196/Jmir.1222 |
0.333 |
|
| 2009 |
Waters EA, Sullivan HW, Finney Rutten LJ. Cancer prevention information-seeking among Hispanic and non-Hispanic users of the National Cancer Institute's Cancer Information Service: trends in telephone and LiveHelp use. Journal of Health Communication. 14: 476-86. PMID 19657927 DOI: 10.1080/10810730903032952 |
0.304 |
|
| 2008 |
Sullivan HW, Burke Beckjord E, Finney Rutten LJ, Hesse BW. Nutrition-related cancer prevention cognitions and behavioral intentions: testing the risk perception attitude framework. Health Education & Behavior : the Official Publication of the Society For Public Health Education. 35: 866-79. PMID 19011220 DOI: 10.1177/1090198108326164 |
0.313 |
|
| 2006 |
Sullivan HW, Worth KA, Baldwin AS, Rothman AJ. The effect of approach and avoidance referents on academic outcomes: A test of competing predictions Motivation and Emotion. 30: 157-164. DOI: 10.1007/S11031-006-9027-8 |
0.63 |
|
| 2005 |
Worth KA, Sullivan HW, Hertel AW, Rothman AJ, Jeffery RW. Avoidance goals can be beneficial: A look at smoking cessation Basic and Applied Social Psychology. 27: 107-116. DOI: 10.1207/S15324834Basp2702_2 |
0.626 |
|
| Show low-probability matches. |